Souhaitez-vous accéder aux communiqués récents ?

IRVINE, CA--(Marketwired - August 10, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that has issued an update on the progress of commercialization of its new IBS diagnostic guided therapy...

IRVINE, CA--(Marketwired - July 25, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it added Edward W. (Ned) Barnholt to a newly formed Strategic Advisory Board and Dr. Anthony J. Lembo to...

IRVINE, CA--(Marketwired - July 18, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it has added Dr. Mark A. Sirgo to its Board of Directors, expanding the Board to six members which...

IRVINE, CA--(Marketwired - July 11, 2016) - Biomerica, Inc. (OTCQB: BMRA) announced today that the U.S. Food and Drug Administration (FDA) has determined that the proposed clinical study to validate...

IRVINE, CA--(Marketwired - May 26, 2016) - Biomerica Inc. (OTCQB: BMRA) today announced that it has entered into an exclusive license agreement with Celtis Pharm Co. Ltd of South Korea granting...

IRVINE, CA--(Marketwired - April 15, 2016) - Biomerica, Inc. (OTCQB: BMRA) today reported net sales of $3,813,683 for the nine months ending February 29, 2016, compared to $3,467,450 for the same...

IRVINE, CA--(Marketwired - April 07, 2016) -  Biomerica Inc. (OTCQB: BMRA) today announced that the Chairman and CEO, along with all of the board members of the Company's board of directors,...

IRVINE, CA--(Marketwired - March 14, 2016) - Biomerica Inc. (OTCBB: BMRA) announced that the International Search Authority (ISA) has deemed that all its International Patent Application claims...

IRVINE, CA--(Marketwired - March 10, 2016) -  Biomerica Inc. (OTCBB: BMRA) ) today announced that Zackary Irani, Chief Executive Officer of Biomerica, will present a business update about...

IRVINE, CA--(Marketwired - January 15, 2016) - Biomerica, Inc. (OTCBB: BMRA) today reported net sales of $1,165,080 for the three months ended November 30, 2015, compared to $1,133,600 for the...